These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37550123)

  • 21. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Kubo T; Shinke T; Okamura T; Hibi K; Nakazawa G; Morino Y; Shite J; Fusazaki T; Otake H; Kozuma K; Ioji T; Kaneda H; Serikawa T; Kataoka T; Okada H; Akasaka T;
    Eur Heart J; 2017 Nov; 38(42):3139-3147. PubMed ID: 29121226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
    Cao D; Vranckx P; Valgimigli M; Sartori S; Angiolillo DJ; Bangalore S; Bhatt DL; Feng Y; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; Choi JW; Campo G; De la Torre Hernandez JM; Krucoff MW; Kunadian V; Sardella G; Spirito A; Thiele H; Varenne O; Vogel B; Zhou Y; Windecker S; Mehran R
    EuroIntervention; 2024 May; 20(10):e630-e642. PubMed ID: 38776146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
    Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk.
    Kornowski R; Konigstein M; Jonas M; Assali A; Vaknin-Assa H; Segev A; Danenberg H; Halabi M; Roguin A; Kerner A; Lev E; Karamasis GV; Johnson TW; Anderson R; Blaxill J; Jadhav S; Hoole S; Witberg G; Issever MO; Ben-Yehuda O; Baumbach A
    J Am Heart Assoc; 2024 Jan; 13(2):e029051. PubMed ID: 38214256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
    Garot P; Brunel P; Dibie A; Morelle JF; Abdellaoui M; Levy R; Carrié D; Karsenty B; Robin C; Berland J; Copt S; Sadozai Slama S; Oldroyd K; Morice MC; Lipiecki J;
    Catheter Cardiovasc Interv; 2023 Jan; 101(1):60-71. PubMed ID: 36378683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of Frequency Domain Optical Coherence Tomography Compared with Intravascular Ultrasound as a Guidance for Percutaneous Coronary Intervention.
    Kim IC; Yoon HJ; Shin ES; Kim MS; Park J; Cho YK; Park HS; Kim H; Nam CW; Han SW; Kim YN; Kim KB; Hur SH
    J Interv Cardiol; 2016 Apr; 29(2):216-24. PubMed ID: 26927366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy.
    Kedhi E; Latib A; Abizaid A; Kandzari D; Kirtane AJ; Mehran R; Price MJ; Simon D; Worthley S; Zaman A; Brar S; Liu M; Stone GW; Windecker S
    Am Heart J; 2019 Aug; 214():134-141. PubMed ID: 31203158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Kedhi E; Verdoia M; Suryapranata H; Damen S; Camaro C; Benit E; Barbieri L; Rasoul S; Liew HB; Polad J; Ahmad WA; Zambahari R; Lalmand J; van der Schaaf RJ; Koh TH; Timmermans P; Dilling-Boer D; Veenstra LF; Van' T Hof AW; Lee SW; Roolvink V; Ligtenberg E; Postma S; Kolkman EJ; Brouwer MA; Dudek D; De Luca G
    Atherosclerosis; 2021 Mar; 321():39-44. PubMed ID: 33639478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
    Valgimigli M; Wlodarczak A; Tölg R; Merkely B; Kelbæk H; Legutko J; Galli S; Godin M; Toth GG; Lhermusier T; Honton B; Dietrich PL; Stammen F; Ferdinande B; Silvain J; Capodanno D; Cayla G;
    Circulation; 2023 Sep; 148(13):989-999. PubMed ID: 37624364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures.
    Choi KH; Song YB; Lee JM; Lee SY; Park TK; Yang JH; Choi JH; Choi SH; Gwon HC; Hahn JY
    JACC Cardiovasc Interv; 2019 Apr; 12(7):607-620. PubMed ID: 30878474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
    Witzenbichler B; Maehara A; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; Xu K; Parise H; Mehran R; Mintz GS; Stone GW
    Circulation; 2014 Jan; 129(4):463-70. PubMed ID: 24281330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Landi A; Alasnag M; Heg D; Frigoli E; Malik FTN; Gomez-Blazquez I; Pourbaix S; Chieffo A; Spaulding C; Sainz F; Routledge H; Andò G; Testa L; Sciahbasi A; Contractor H; Jepson N; Mieres J; Imran SS; Noor H; Smits PC; Valgimigli M;
    JAMA Cardiol; 2024 Jan; 9(1):35-44. PubMed ID: 37991745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
    Stone GW; Christiansen EH; Ali ZA; Andreasen LN; Maehara A; Ahmad Y; Landmesser U; Holm NR
    Lancet; 2024 Mar; 403(10429):824-837. PubMed ID: 38401549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.
    Muramatsu T; Ozaki Y; Nanasato M; Ishikawa M; Nagasaka R; Ohota M; Hashimoto Y; Yoshiki Y; Takatsu H; Ito K; Kamiya H; Yoshida Y; Murohara T; Izawa H;
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009314. PubMed ID: 33106049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI.
    Yamamoto K; Watanabe H; Morimoto T; Obayashi Y; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    JACC Asia; 2023 Feb; 3(1):31-46. PubMed ID: 36873770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Kedhi E; Delewi R; Fabris E; De Luca G; Hermanides RS; van den Ent M; Buszman P; Zijlstra F; Song YB; Gwon HC; Hahn JY
    Atherosclerosis; 2020 Dec; 315():55-61. PubMed ID: 33227548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
    Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
    J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial.
    Yamamoto K; Watanabe H; Morimoto T; Domei T; Ohya M; Ogita M; Takagi K; Suzuki H; Nikaido A; Ishii M; Fujii S; Natsuaki M; Yasuda S; Kaneko T; Tamura T; Tamura T; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Igarashi Hanaoka K; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Circ Cardiovasc Interv; 2021 May; 14(5):e010384. PubMed ID: 34003662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Gallone G; D'Ascenzo F; Boccuzzi G; Cortese B; Di Biasi M; Omedè P; Capodanno D; Cerrato E; Vicinelli P; Infantino V; Poli A; Ugo F; Conrotto F; Grigis G; Varbella F; Latini RA; D'Urbano M; Montabone A; Senatore G; Ferrara E; D'Amico M; De Ferrari GM; Ielasi A
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E248-E256. PubMed ID: 32012453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
    Hong SJ; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Her AY; Kim YH; Jang Y; Hong MK;
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1438-46. PubMed ID: 27212028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.